Diferencia entre revisiones de «Template:Ischemic Stroke Cause»

 
(No se muestran 4 ediciones intermedias de 2 usuarios)
Línea 11: Línea 11:
*Embolic (20% of ischemic CVA)
*Embolic (20% of ischemic CVA)
**[[endocarditis|Valvular vegetations]]
**[[endocarditis|Valvular vegetations]]
**Mural thrombi
**[[Mural thrombi]]
**Arterial-arterial emboli from proximal source (ex. ''[[amaurosis fugax]]'' -> emboli from a proximal carotid artery plaque embolizes to the ophthalmic artery, causing transient monocular blindness)
**Arterial-arterial emboli from proximal source (ex. ''[[amaurosis fugax]]'' -> emboli from a proximal carotid artery plaque embolizes to the ophthalmic artery, causing transient monocular blindness)
**[[Fat embolism syndrome|Fat emboli]]
**[[Fat embolism syndrome|Fat emboli]]
Línea 17: Línea 17:
*[[Shock|Hypoperfusion]]
*[[Shock|Hypoperfusion]]
**Cardiac failure resulting in systemic hypotension
**Cardiac failure resulting in systemic hypotension
*Cryptogenic
**Cryptogenic Stroke (CS) is defined as an Ischemic stroke of obscure or unknown origin. Its causes are unknown. It is transitory or reversible.<ref>[Finsterer J. Management of cryptogenic stroke. Acta Neurol Belg. 2010 Jun;110(2):135-47. PMID: 20873443].</ref>

Revisión actual - 15:43 26 dic 2023

Ischemic stroke causes (87%)

  1. [Finsterer J. Management of cryptogenic stroke. Acta Neurol Belg. 2010 Jun;110(2):135-47. PMID: 20873443].